...
首页> 外文期刊>Journal of neurology >Neurogenetics: T1 level translational research, myopathies and moyamoya disease.
【24h】

Neurogenetics: T1 level translational research, myopathies and moyamoya disease.

机译:神经遗传学:T1级转化研究,肌病和烟雾病。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Translationai research and translating research into treatments are major issues for clinicians and patients. T1 level translationai research is research that bridges a basic science observation from the bench to a clinical investigation at the bedside (for references See Noseworthy et al. 2008). T2 research may extend an observation from a clinical research population to research in an entire community. Such research can also work in the other direction: from observations in patients back to the bench to refine or improve potential treatments, which can then re-enter the cycle. The first article, which is accompanied by an Editorial and an Editorial Note in Neurology, is such an example. It demonstrates a lack of toxicity of alpha-sarcoglycan overexpression, which is an important step in the multi-step process of clinical gene therapy, in this case in limb-girdle muscular dystrophy. The second and third articles - both also published in Neurology - show in single patients that stem cell transplantation may cure patients with a sporadic late-onset nemaline myopathy (SLONM) associated with a monoclonal IgG gam-mopathy. These two short articles were also chosen to broaden our differential diagnosis spectrum because the affected patients might be misdiagnosed as having an atypical form of amyotrophic lateral sclerosis.
机译:Translationai研究和将研究转化为治疗是临床医生和患者的主要问题。 T1级翻译研究是将基础科学观察从实验台延伸到床旁临床研究的桥梁(有关参考,请参见Noseworthy等人2008)。 T2研究可以将观察范围从临床研究人群扩展到整个社区的研究。这样的研究也可以朝另一个方向进行:从对患者的观察再到工作台,以完善或改进潜在的治疗方法,然后可以重新进入治疗周期。这样的例子就是第一篇文章,其中附有神经病学社论和社论说明。它证明了缺乏α-糖聚糖过表达的毒性,这是临床基因治疗的多步骤过程中的重要步骤,在这种情况下是肢带型肌营养不良症。第二篇和第三篇文章(也都发表在《神经病学》上)表明,在单例患者中,干细胞移植可以治愈伴有单克隆IgG gam-mopathy的散发性迟发性肾上腺肌病(SLONM)的患者。选择这两个简短的文章也是为了扩大我们的鉴别诊断范围,因为受影响的患者可能被误诊为非典型形式的肌萎缩性侧索硬化症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号